SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-15-004011
Filing Date
2015-12-09
Accepted
2015-12-09 16:15:31
Documents
2
Period of Report
2015-12-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ANIKA THERAPEUTICS, INC. 8-K a51239898.htm 8-K 34840
2 EXHIBIT 10.1 a51239898_ex101.htm EX-10.1 47556
  Complete submission text file 0001157523-15-004011.txt   83885
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 151278527
SIC: 3841 Surgical & Medical Instruments & Apparatus